You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell Prolymphocytic Leukemia (T-PLL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, T-cell Prolymphocytic Leukemia (T-PLL), Cancer Trial in Worldwide (Venetoclax, Ibrutinib)

Completed
Has Results
  • Leukemia
  • +2 more
  • Boston, Massachusetts
  • +14 more
Nov 23, 2022

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    T-Prolymphocytic Leukemia Trial in Duarte, Columbus, Houston (APG-115, APG-2575)

    Recruiting
    • T-Prolymphocytic Leukemia
    • Duarte, California
    • +2 more
    Jul 8, 2022

    T-cell-prolymphocytic Leukemia Trial in Cologne (Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab, Alemtuzumab)

    Completed
    • T-cell-prolymphocytic Leukemia
    • Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
    • Alemtuzumab
    • Cologne, Germany
      University Hospital Cologne
    Dec 16, 2021

    T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

    Not yet recruiting
    • T-Cell Non-Hodgkin Lymphoma
    • +14 more
    • WU-CART-007
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 17, 2023

    Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

    Recruiting
    • Recurrent Acute Lymphoblastic Leukemia
    • +15 more
    • Anti-CD19/CD20/CD22 CAR T-Cells
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 4, 2022

    Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial

    Active, not recruiting
    • Contiguous Stage II Small Lymphocytic Lymphoma
    • +11 more
    • MOR00208
    • +2 more
    • Columbus, Ohio
      The Ohio State University Comprehensive Cancer Center
    Feb 24, 2022

    T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,

    Completed
    Has Results
    • T-Cell Lymphoma Relapsed
    • +4 more
    • IL-15 plus
    • alemtuzumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 27, 2022

    Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,

    Recruiting
    • Cutaneous T-cell Lymphoma
    • +4 more
    • Columbus, Ohio
      The Ohio State University Cancer Center
    Apr 18, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial in Columbus (acalabrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Columbus, Ohio
      Research Site
    Mar 11, 2022

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

    Not yet recruiting
    • Leukemia, Acute
    • +7 more
    • (no location specified)
    Apr 10, 2023

    T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • Hangzhou, Zhejiang, China
      The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
    Aug 7, 2023

    B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Peripheral T-Cell Lymphoma Trial in Columbus (Letermovir)

    Recruiting
    • B-Cell Prolymphocytic Leukemia
    • +5 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 18, 2022

    Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

    Recruiting
    • Extranodal NK T Cell Lymphoma
    • NK-Cell Leukemia
    • Anti-CD56 CAR T
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Jul 10, 2023

    T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

    Not yet recruiting
    • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • CD7-CART01
    • (no location specified)
    Sep 26, 2023

    Lymphoma, Non-Hodgkin, Lymphoma, T-Cell Trial in Najing (Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Lymphoma, T-Cell
    • Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection
    • Najing, Jiangsu, China
      Jiangsu Provincial People's Hospital
    Sep 26, 2022

    T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)

    Recruiting
    • T-Cell Acute Lymphocytic Leukemia
    • CD7 CAR-T
    • Langfang, Hebei, China
      Hebei Yanda Hospital
    Jun 26, 2023

    B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • CD19/CD22-bispecific CAR-T cells
    • Beijing, Beijing, China
      Liang Wang
    Oct 7, 2023

    T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • CD7 CAR-T cells
    • Shenzhen, Guangdong, China
      Li Yu
    Nov 11, 2022

    Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

    Recruiting
    • Lymphoblastic Lymphoma
    • +2 more
    • BEAM-201
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jun 2, 2023

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti Tim-3/CD123 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 4, 2023

    B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

    Recruiting
    • B-Cell Non Hodgkin Lymphoma
    • B-Cell Acute Lymphoblastic Leukemia
    • anti-CD19 CAR T-cells
    • Hanoi, Vietnam
      Vinmec Research Institute of Stem Cell and Gene Technology
    Sep 5, 2023

    T-cell Acute Lymphoblastic Leukemia, Lymphoblastic T-Cell Lymphoma Trial in Barcelona (CD1a-CAR T)

    Not yet recruiting
    • T-cell Acute Lymphoblastic Leukemia
    • Lymphoblastic T-Cell Lymphoma
    • CD1a-CAR T
    • Barcelona, Spain
    • +1 more
    Jan 10, 2023

    B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, Unspecified Trial in Guangzhou, Guanzhou (CD19 CAR T-Cell(CAT19T2))

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-Cell Lymphoma, Unspecified
    • CD19 CAR T-Cell(CAT19T2)
    • Guangzhou, Guangdong, China
    • +1 more
    Nov 4, 2022